Finished
Single Port Insufflation RCT
NCT06990750 · University of Chicago · Updated 6 Feb 2026
- What is being tested
- 15 mmHg; 12 mmHg
- For
- Postoperative Pain Score
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 70 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 1 April 2024, ends 1 April 2025. Registered 25 May 2025.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is to learn if decreasing insufflation pressure during minimally invasive single port robotic sacrocolpopexy improved postoperative pain without impacting surgeon intraoperative visualization. The main question it aims to answer is: Does minimally decreasing insufflation pressure improve postoperative pain? Researchers will compare standard insufflation pressure (15 mmHg) to experimental insufflation pressure (12 mmHg) to see if it insufflation pressure impacts patient's postoperative pain. Once a participants agrees to participate in our study, they will receive either standard or experimental pressure at the time of surgery. Postoperative pain scores in the postoperative anesthesia care unit and at postoperative day 1 and 14 visits will be recorded. Participants will also be asked to complete the Patient Global Impression of Improvement at the 14 day visit.
Sites
- The University of ChicagoChicago, Illinois, United States
